Displaying drugs 14426 - 14450 of 15008 in total
GSK-1292263
GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.
Investigational
Indole-3-carbinol
Indole 3 Carbinol is under investigation in clinical trial NCT00033345 (Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer).
Investigational
Iopydol
Experimental
Obidoxime
Experimental
Indirubin-3'-monoxime
Experimental
Biliverdine IX Alpha
Experimental
Chlorophyll A
Experimental
Pyridoxamine-5'-Phosphate
Experimental
Indole-3-Propanol Phosphate
Experimental
RU79073
Experimental
Fe-Mesopone
Experimental
Implitapide
Implitapide is a microsomal triglyceride transfer protein (MTP)-inhibitor.
Investigational
Pipendoxifene
ER modulator, ERA-923(Pipendoxifene) is a estrogen receptor modulator being evaluated for the treatment of breast cancer. Pipendoxifene is a new 2-phenyl indole selective estrogen receptor modulators (SERM )that exhibits an excellent preclinical pharmacological profile and was selected for further development as a treatment for metastatic breast cancer.
Investigational
Matched Description: … estrogen receptor modulators (SERM )that exhibits an excellent preclinical pharmacological profile and …
4-O-Demethylpenclomedine
Investigational
Displaying drugs 14426 - 14450 of 15008 in total